Get A Quote

Antibiotics

    Catalog Product Name / CAS / Description Structure
    BBF-01529

    Kapurimycin A1 (132412-65-8)

    Inquiry

    It is originally isolated from Str. sp. DO-15. Kapurimycin A1 can resist gram-positive bacteria and a few gram-negative bacteria.

    BBF-01530

    Kapurimycin A2 (132412-64-7)

    Inquiry

    It is originally isolated from Str. sp. DO-15. Kapurimycin A2 can resist gram-positive bacteria and a few gram-negative bacteria.

    BBF-01531

    Kapurimycin A3 (129966-45-6)

    Inquiry

    It is originally isolated from Str. sp. DO-15. Kapurimycin A3 can resist gram-positive bacteria and a few gram-negative bacteria.

    BBF-01532

    Karalicin is produced by the strain of Pseudomonus fluorescens/putida SS-3. It inhibits herpes simplex virus HSV-1, HSV-2, vaccinia virus, polio virus type I with the IC50 (μg/mL) of 0.004, 0.008, 0.016 and 0.016.

    BBF-01533

    Katanosin A (116103-86-7)

    Inquiry

    Katanosin A is a peptide antibiotic originally isolated from Cytophaga sp. PBJ-5356. It has anti-gram-positive bacterial effect.

    BBF-01534

    Lysobactin (118374-47-3)

    Inquiry

    Lysobactin, also known as katanosin B, is a potent antibiotic with in vivo efficacy against Staphylococcus aureus and Streptococcus pneumoniae. It was previously shown to inhibit peptidoglycan (PG) biosynthesis.

    BBF-01535

    Kerriamycin A (98474-20-5)

    Inquiry

    Produced by the strain of Str. Violaceolatus, Kerriamycin A has anti-gram-positive bacterial effect and can also prolong the survival time of patients with Ai's ascites cancer.

    BBF-01536

    Kerriamycin C (98495-38-6)

    Inquiry

    It is produced by the strain of Str. Violaceolatus. Kerriamycin C has anti-gram-positive bacterial effect and can also prolong the survival time of patients with Ai's ascites cancer.

    BBF-01538

    Kibdelin A (103528-50-3)

    Inquiry

    Kibdelin A is originally isolated from Kibdelosporangium aridum subsp. largum SKF AAD-609. Kibdelin A is resistant to gram-positive bacteria and has similar effects against Staphylococcus aureus (including methicillin-resistant strains) as vancomycin.

    BBF-01539

    Kibdelin B (103528-49-0)

    Inquiry

    Kibdelin B is originally isolated from Kibdelosporangium aridum subsp. largum SKF AAD-609. Kibdelin B is resistant to gram-positive bacteria and has similar effects against Staphylococcus aureus (including methicillin-resistant strains) as vancomycin.

    BBF-01540

    Kibdelin C1 (103549-47-9)

    Inquiry

    Kibdelin C1 is originally isolated from Kibdelosporangium aridum subsp. largum SKF AAD-609. Kibdelin C1 is resistant to gram-positive bacteria and has similar effects against Staphylococcus aureus (including methicillin-resistant strains) as vancomycin.

    BBF-01541

    Kibdelin C2 (105997-85-1)

    Inquiry

    Kibdelin C2 is originally isolated from Kibdelosporangium aridum subsp. largum SKF AAD-609. Kibdelin C2 is resistant to gram-positive bacteria and has similar effects against Staphylococcus aureus (including methicillin-resistant strains) as vancomycin.

    BBF-01542

    Kibdelin D (105997-86-2)

    Inquiry

    Kibdelin D is originally isolated from Kibdelosporangium aridum subsp. largum SKF AAD-609. Kibdelin D is resistant to gram-positive bacteria and has similar effects against Staphylococcus aureus (including methicillin-resistant strains) as vancomycin.

    BBF-01543

    Kigamicin A is produced by the strain of Amycolatopsis sp. ML-630-mFl. It showed activity against gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) with MIC of 0.025-0.78 μg/mL.

    BBF-01544

    Kigamicin B is produced by the strain of Amycolatopsis sp. ML-630-mFl. It showed activity against gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) with MIC of 0.025-0.78 μg/mL.

    BBF-01545

    Kigamicin D is produced by the strain of Amycolatopsis sp. ML-630-mFl. It showed activity against gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) with MIC of 0.025-0.78 μg/mL. It also shows effect against L-1210 LB32T and other genera tumor cells with IC50 of 1 μg/mL.

    BBF-01546

    Kinamycin A (35303-12-9)

    Inquiry

    Kinamycin A is produced by the strain of Str. murayamaensis. Kinamycin A has antibacterial and mycobacterial effects, but it has weak activity against gram-negative bacteria.

    BBF-01547

    Kinamycin B (35303-13-0)

    Inquiry

    Kinamycin B is produced by the strain of Str. murayamaensis. Kinamycin B has antibacterial and mycobacterial effects, but it has weak activity against gram-negative bacteria.

    BBF-01548

    Kistamicin A (155683-50-4)

    Inquiry

    Kistamicin A is produced by the strain of Microtetraspora parvasata subsp. kistna. It has antiviral effect, and its ID50 (μg/mL) against influenza virus MDCK cells and herpes simplex virus are respectively 3.6 and 44. It also has anti-gram-positive bacterial effects.

    BBF-01549

    Kistamicin B (155683-51-5)

    Inquiry

    Kistamicin B is produced by the strain of Microtetraspora parvasata subsp. kistna. It has antiviral effect, and its ID50 (μg/mL) against influenza virus MDCK cells and herpes simplex virus are respectively 1.8 and 30.

    Copyright © 2025 BOC Sciences. All rights reserved.

    cartIcon
    Inquiry Basket